Global Non-Invasive Prenatal Testing (NIPT) Market Research Report: By Product Type (Devices, Consumables, Others), By Techniques (Biochemical Screening Tests, Ultrasound Detection), By Application (Trisomy, Microdeletion syndrome, Others) and By End-User (Diagnostic Laboratories, Hospitals, cell DNA screening) – Forecast to 2025
Market Highlights:
According to MRFR analysis, the global NIPT market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018.
NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition. These devices and procedures are used for applications. As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births. The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.
However, less accuracy of non-invasive prenatal testing compared to invasive prenatal testing is likely to hamper the growth of the global NIPT market during the forecast period.
Several market players currently dominate the global NIPT market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.
Market Drivers
- Growing global population.
- Adoption of unhealthy lifestyle habits during pregnancy.
- Rising awareness of non-invasive prenatal testing.
Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8371
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced NIPT procedures. The non-invasive prenatal testing market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.
The non-invasive prenatal testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is anticipated to hold the largest market share owing to the increasing number of increasing population and rising adoption of technological advancements in developing regions. The European NIPT market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The non-invasive testing market in the Middle East & Africa has been divided into the Middle East and Africa.
Segmentation
The global NIPT market has been segmented based on product type, techniques, application, and end user.
The market, based on product type, has been divided into devices, consumables, and others. The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others. The devices are likely to hold the maximum market share in the global NIPT market. Consumables are further segmented into assay kits & reagents, disposables, and others.
The global NIPT market on the basis of techniques has been segregated into biochemical screening tests and ultrasound detection.
On the basis of application, the global non-invasive prenatal testing market is segmented into trisomy microdeletion syndrome and others.
The end user segment of the market consists of diagnostic laboratories, hospitals, and research institutes. The diagnostic laboratories segment is expected to hold the largest share of the market as these centers are primary locations for patients receiving non-invasive prenatal testing.
Access Report Details @ https://www.marketresearchfuture.com/reports/non-invasive-prenatal-testing-market-8371
Global Market – Competitive Dashboard
Some of the key players in the global NIPT market are Laboratory Corporation of America Holdings (US), Natera, Inc, Yourgene Health (UK), Centogene Holding AG [CENTOGENE AG ] (Germany), Agilent Technologies, Inc, Beijing Genomics Institute (China), General Electric Company [GE Healthcare] (US), Illumina, Inc, Perkinelmer, Inc, PhytoHealth Corporation (Taiwan), Tarsa Therapeutics, Inc, Thermo Fisher Scientific, Inc, and F Hoffman-La Roche Ltd.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
According to the new market research report “Non-Invasive Prenatal Testing Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.
Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
However, a dearth of skilled professionals is restraining the growth of this market.Key Players in the Global NIPT MarketThe NIPT market is diversified and highly competitive, with a large number of players competing for market space.
The prominent players in the market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), GE Healthcare (US), BGI (China), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer Inc. (US), Laboratory Corporation of America Holdings (US), Natera, Inc. (US), and Yourgene Health (UK)Inquire or share your questions if any before the purchasing this report: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=145607690Growth prospects in Non Invasive Prenatal Testing (NIPT) Market :The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.
However, a dearth of skilled professionals is restraining the growth of this market.By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.
The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period.Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).
The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market.
The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.
[144 Pages Report] The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
However, a dearth of skilled professionals is restraining the growth of this market.Market DynamicsHigh Risk of Chromosomal Abnormalities With Increasing Maternal AgeGrowing Preference for Noninvasive Techniques Over Invasive MethodsImproving Reimbursement Scenario for NIPTPrograms Focusing on Increasing the Awareness of NIPTThe trisomy applications segment accounted for the largest share of the global NIPT market in 2018.Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).
This segment is also estimated to grow at the highest CAGR during the forecast period.
The large share and high growth of this segment can primarily be attributed to factors such as the increasing maternal age and the rising incidence of chromosomal abnormalities.Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.
Global Non-Invasive Prenatal Testing (NIPT) Market Research Report: By Product Type (Devices, Consumables, Others), By Techniques (Biochemical Screening Tests, Ultrasound Detection), By Application (Trisomy, Microdeletion syndrome, Others) and By End-User (Diagnostic Laboratories, Hospitals, cell DNA screening) – Forecast to 2025Market Highlights:According to MRFR analysis, the global NIPT market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018.NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition.
As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births.
The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.However, less accuracy of non-invasive prenatal testing compared to invasive prenatal testing is likely to hamper the growth of the global NIPT market during the forecast period.Several market players currently dominate the global NIPT market.
The key players are involved in product launches and strategic collaborations to strengthen their market positions.Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8371 Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced NIPT procedures.
The non-invasive prenatal testing market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.The non-invasive prenatal testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others.
